Patent · US Active

Combination of the application of antibodies for immunostimulation together with glucocorticoids

US10071158B2 · kind B2 · utility

1Cited by

55References

20Claims

0Family size

Assignee

Lindis Biotech GmbH · DE

Inventors

Markus M. Heiss · Cologne, DE
Horst Lindhofer · Puchheim, DE

Key dates

Filing date	Apr 7, 2014
Grant date	Sep 11, 2018
Priority date	—
Expiry date	Apr 7, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/31
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to methods for reducing or eliminating the non-specific release of a cytokine associated with a disease comprising administering at least one glucocorticoid and an immunostimulating antibody. Additionally, the present invention relates to a pharmaceutical composition that contains at least one immunostimulating antibody and at least one glucocorticoid.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.